In 2020, Oregon voters approved Ballot Measure 109, which legalized the production, distribution, and administration of psilocybin for therapeutic purposes.

PsyCon is the preeminent conference and trade show for this new psychedelic market, bringing together the nation’s most respected experts, thought leaders, and entrepreneurs currently on the cutting edge of this exciting (and quickly emerging) space.

Featuring a wide array of panels, dozens of fascinating exhibits, and plenty of time for networking, PsyCon is the place to be for psychedelic professionals, interested newcomers, and consumers alike. No medical card is required.

PsyCon is the premier conference and trade show for the booming psychedelic industry. Featuring expert panels from across the space, cutting-edge exhibits from top companies, and plenty of space for meaningful conversation, PsyCon is paving the way for the next generation of psychedelic businesses. Focused on emerging markets, our events strive to cultivate connections while promoting education and innovation.

A new era in healthcare is quickly emerging, focused on alternative therapies that show incredible promise for a wide range of debilitating conditions. From ketamine therapy to psilocybin microdosing, there is more interest than ever in entheogenic medicine. With a projected value of over $10 billion within a few short years, and several clinical trials underway, the sky’s the limit for the psychedelic industry.

The psychedelic renaissance is upon us. PsyCon is honored to be a part of history as it happens.